88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $31 million upfront, and up to $270 million in ... 2025-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PHASE Scientific Earns Prestigious Recognition at 2025 ASCCP Scientific Meeting for Innovation in Urine-Based HPV Screening SAN DIEGO , April 29, 2025 /PRNewswire/ -- PHASE Scientific (PHASE) proudly announced a major milestone this week with its inaugural participation and award-winning presentation at the 2025 American ... 2025-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Metabolon Launches Microbiome Research Solution Combining New Microbiome Panel, Metagenomics Sequencing, and Multiomics Bioinformatics Tools The combination of metagenomics and metabolomics data, integrated within an intuitive bioinformatics platform, enables deeper microbiome insights than possible with either approach individually ... 2025-04-29T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering positive impact to communities ... 2025-04-29T Biotechnology Environmental Products & Services Health Care/Hospital Medical/Pharmaceuticals
Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing New findings suggest 'BluePDRN™' offers a sustainable, scalable alternative to traditional animal-derived PDRNs ... 2025-04-29T Biotechnology Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025 SHANGHAI , April 29, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating ... 2025-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news
AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025 HONG KONG , April 29, 2025 /PRNewswire/ -- Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded ... 2025-04-29T Banking/Financial Service Biotechnology Computer/Electronics Health Care/Hospital
KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS THE WORLD'S MOST PRESTIGIOUS OSTEOARTHRITIS SOCIETY (OARSI) HELD FOR THE FIRST TIME IN KOREA LONG-TERM SAFETY DATA FROM OVER 1 5 YEARS SUPPORT THE SAFETY PROFILE OF TG-C, WITH PRELIMINARY ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Complete Genomics, Velsera partner to integrate sequencing and analysis platforms CHICAGO , April 28, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera , a leading global healthcare technology company, ... 2025-04-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE HEFEI, China , April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved